Li Keqiang calls for basic drug catalog adjustment to focus on cancer, pediatrics, chronic diseases and other diseases


Premier Li Keqiang presided over a State Council executive meeting on Aug. 30, which decided to transfer 187 Chinese and Western medicines with clear effectiveness and safety, and significant cost-benefit ratios, to the national essential drugs catalog.

"The adjustment of the basic drug catalog should focus on major diseases that affect the health of the masses." Li said.

Essential drugs are medicines that are adapted to basic medical and healthcare needs, in appropriate dosage forms and at reasonable prices, and are able to guarantee supply and fair access to the public. The national essential drugs catalog is the basis for medical and health institutions at all levels to equip and use medicines. Since the new round of medical reform, the establishment and implementation of the national essential drug system has played an important role in improving the drug supply guarantee system, guaranteeing the basic use of drugs by the public, and reducing the burden of medication on patients.

Among the 187 medicines to be transferred, there are 12 kinds of oncology medicines, including 6 kinds of targeted therapy medicines; 22 kinds of clinically urgently needed children's medicines; and the world's first and only oral, pan-genotypic, and single-tablet new medicines for the treatment of hepatitis C have been included.

Li Keqiang pointed out at the executive meeting on August 30 that improving the national essential drug system is an important initiative to deepen medical reform and strengthen basic public services in healthcare, which is conducive to meeting the basic drug needs of the masses.

The meeting on the same day decided that the basic drug catalog should be adjusted in a timely manner. The adjustment, on the basis of covering the main clinical diseases, focusing on cancer, pediatrics, chronic diseases and other diseases, transferred into the effectiveness and safety of a clear, cost-effective ratio of 187 kinds of Chinese and Western medicines, including 12 kinds of oncology medicines, 22 kinds of clinically needed children's medicines, which are significantly more than the original directory. After the adjustment, the total varieties of the basic drug catalog were expanded to 685. The meeting also decided that in the future, newly approved and listed drugs with significantly improved efficacy and reasonable prices will be expedited.

Li Keqiang asked that the basic drug system be linked with the basic health insurance to effectively reduce the burden of drug costs on patients. "It is necessary to promote centralized band purchasing in public medical institutions and other ways to push down drug prices. Establish a mechanism for linking basic drugs and basic health insurance and guaranteeing the sustainability of health insurance, and prioritize the inclusion of eligible therapeutic drugs in the basic drug catalog into the health insurance catalog in accordance with procedures, so that health insurance can benefit the insured more." The Premier said.

Premier Li Keqiang presided over a State Council executive meeting on Aug. 30, which decided to transfer 187 Chinese and Western medicines with clear effectiveness and safety, and significant cost-benefit ratios, into the national basic drug catalog.

"The adjustment of the basic drug catalog should focus on major diseases that affect the health of the masses." Li said.

Essential drugs are medicines that are adapted to basic medical and healthcare needs, in appropriate dosage forms and at reasonable prices, and are able to guarantee supply and fair access to the public. The national essential drugs catalog is the basis for the provision and use of medicines in medical and healthcare institutions at all levels. Since the new round of medical reform, the establishment and implementation of the national essential drug system has played an important role in improving the drug supply guarantee system, guaranteeing the basic use of drugs by the public, and reducing the burden of medication on patients.

Among the 187 medicines to be transferred, there are 12 kinds of oncology medicines, including 6 kinds of targeted therapy medicines; 22 kinds of clinically urgently needed children's medicines; and the world's first and only oral, pan-genotypic, and single-tablet new medicines for the treatment of hepatitis C have been included.

Li Keqiang pointed out at the executive meeting on August 30 that improving the national essential drug system is an important initiative to deepen medical reform and strengthen basic public services in healthcare, which is conducive to meeting the basic drug needs of the masses.

The meeting on the same day decided that the basic drug catalog should be adjusted in a timely manner. The adjustment, on the basis of covering the main clinical diseases, focusing on cancer, pediatrics, chronic diseases and other diseases, transferred into the effectiveness and safety of a clear, cost-effective ratio of 187 kinds of Chinese and Western medicines, including 12 kinds of oncology medicines, 22 kinds of clinically needed children's medicines, which are significantly more than the original directory. After the adjustment, the total varieties of the basic drug catalog were expanded to 685. The meeting also decided that in the future, newly approved and listed drugs with significantly improved efficacy and reasonable prices will be expedited.

Li Keqiang asked that the basic drug system be linked with the basic health insurance to effectively reduce the burden of drug costs on patients. "It is necessary to promote centralized band purchasing in public medical institutions and other ways to push down drug prices. Establish a mechanism for linking basic drugs and basic health insurance and guaranteeing the sustainability of health insurance, and prioritize the inclusion of eligible therapeutic drugs in the basic drug catalog into the health insurance catalog in accordance with procedures, so that health insurance can benefit the insured more." The Premier said.

He said that while playing a guiding role in the basic drug catalog, we should allow localities to combine local realities, calculate the balance of health insurance account, focus on doing a good job in the "basic", and effectively reduce the burden on patients.

Li Keqiang emphasized that we must ensure that basic drugs are constantly available. The amount of small and other essential drugs that are prone to shortages, can be taken into account in the production of fixed-point, into the reserve and other measures to ensure the supply. Public medical institutions should give priority to the use of basic drugs, the use of which is linked to the allocation of relevant subsidies. At the same time, drug quality and safety supervision should be strengthened.

"For the people, there is nothing bigger than life and health." The Premier said, "All relevant localities and departments should effectively shoulder their responsibilities, strengthen drug quality and safety supervision, and ensure that the public can use medicines safely and securely."

He said that while playing a guiding role in the basic drug catalog, localities should be allowed to combine local realities and calculate the balance of health insurance, focusing on the "basic", and effectively reduce the burden on patients.

Li Keqiang emphasized that we must ensure that basic drugs are constantly available. The amount of small and other essential drugs that are prone to shortages, can be taken into account in the production of fixed-point, into the reserve and other measures to ensure the supply. Public medical institutions should give priority to the use of basic drugs, the use of which is linked to the allocation of relevant subsidies. At the same time, drug quality and safety supervision should be strengthened.

"For the people, there is nothing bigger than life and health." The Premier said, "All relevant localities and departments should effectively shoulder their responsibilities, strengthen drug quality and safety supervision, and ensure that the public can use medicines safely and securely."

Other Dynamics


Mitiglinide Calcium Capsules The new version of the medical insurance catalog of clinical application advantages of analysis

Early-phase insulin secretion defect is a characteristic manifestation of abnormal insulin secretion pattern in type 2 diabetes mellitus patients, and insulinotropic agents have an important role in the treatment of type 2 diabetes mellitus. Coinciding with the successful entry of the new mealtime insulinotropic agent, Miglinide calcium, into the new version of the national health insurance catalog, Diabetes International invited Prof. Mou Yiming of the General Hospital of the Chinese People's Liberation Army to explain the advantages of the application and the applicable population of Miglinide calcium, and to analyze the benefits that will be provided to the patients after its entry into the health insurance.


Explanation of pharmacological effects of Miglinide calcium in the new version of the medical insurance catalog

Defective β-cell insulin secretion is one of the central aspects of the pathogenesis of type 2 diabetes. Coinciding with the successful entry of the new mealtime insulinotropic agent, Miglinide calcium, into the new version of the National Health Insurance Catalog, Diabetes International invited Prof. Zhigang Zhao of the Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, to make a professional analysis of the advantages of the action of the new insulinotropic agent from the perspective of pharmacology.


Effective reduction of postprandial hyperglycemia preferred medication - Miglinide calcium capsule

What's worse, the probability of diabetes is increasing among people under the age of 40, as well as pregnant women, and even primary and secondary school students in China.


Golden single product, the heart and brain with treatment - Yixinone dispersible tablets

According to the World Health Organization: the number of people suffering from cardiovascular disease in China has reached 300 million, i.e. 2 out of every 10 adults suffer from cardiovascular disease.


Pioglitazone is the preferred drug for the treatment of type 2 diabetes mellitus.

Diabetes mellitus is a disorder of sugar, fat and protein metabolism caused by a defect in insulin secretion or a decrease in the sensitivity of body tissues and cells to insulin. It is characterized by high blood glucose and is often characterized by excessive urination, drinking, eating and wasting, i.e. "three more and one less".


Drug procurement "national first standard" came drug companies or face different situations

On November 15, the full text of the "4+7" Cities Drug Centralized Purchasing Document was published. With the consent of the Central Committee for Comprehensively Deepening Reform, the State organized a pilot centralized procurement of medicines, and the scope of the pilot area is Beijing, Tianjin, Shanghai, Chongqing, as well as Shenyang, Dalian, Xiamen, Guangzhou, Shenzhen, Chengdu, Xi'an, and other 11 cities (referred to as the "4 + 7 cities"). According to the procurement documents, the first batch of banded procurement catalog totaled 31 varieties, including cefuroxime tablets, escitalopram oxalate tablets, and resuvastatin calcium tablets that have been full of three enterprises through consistency evaluation.